Melanotan 2
Payment Options
Melanotan 2, 10 mg - Hilma Biocare
This is an alpha-MSH analogue peptide, listed as a 10 mg vial of powder.
Manufacturer
Active substance
Melanotan II
Class
α-MSH analogue peptide
Vial content
10 mg
Presentation
Powder for reconstitution
Listed route
Subcutaneous injection
How It Works
The peptide activates melanocortin receptors. At MC1 receptors in pigment cells, this increases melanin production and darkens the skin. Activity at central melanocortin receptors also influences sexual responses and appetite, which explains effects beyond pigmentation.
Skin Pigmentation and Physique Presentation
Small human studies demonstrate increased skin pigmentation after Melanotan II exposure. This is the effect relevant to a darker skin tone for physique presentation. Human research also records erectile responses, reflecting activity at receptor pathways outside the skin.
- Increasing melanin production.
- Increasing skin pigmentation in small human studies.
- Activating melanocortin pathways involved in sexual responses.
Post Cycle Therapy
Melanotan II does not act as an androgen and has no established requirement for steroid style PCT. Its pigment and central receptor effects are separate from recovery of natural testosterone after anabolic steroid use.
Side Effects
Nausea, flushing, yawning, fatigue, appetite reduction and spontaneous or prolonged erections are reported. Darkening of freckles and moles, uneven pigmentation and new pigmented lesions are concerns. Serious systemic reactions have been reported, while long duration safety remains insufficiently characterised. A darker skin tone does not provide reliable protection from ultraviolet damage.










